The E3 ubiquitin ligase TRAF6 directly interacts with PKM2, promoting PKM2-mediated glycolysis and enhancing drug resistance, as demonstrated in both preclinical models and clinical tumor samples (57). The gene discussed is PKM; the disease is neoplasm.